Adocia (fast-acting insulin backed by Eli Lilly) on hold
13/04/2017
No Comments
Eli Lilly has decided to terminate its partnership with Adocia for the development of BioChaperone Lispro, an ultra-rapid insulin for diabetes. Despite results from 6
